N
IMMU

Natixis’s Immunomedics Inc IMMU Stock Holding History

Natixis’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-131,559
Closed -$11.2M – 1133
2020
Q3 		$11.2M Sell
131,559
-231,566
-64% -$11.7M 0.08% 180
2020
Q2 		$12.9M Buy
+363,125
New +$10.6M 0.1% 161

Natixis's IMMU Position: Q4 2020 in Review

Natixis sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 131,559 shares — an estimated $11.2M sold.

Natixis first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $12.9M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Natixis reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Natixis sold 131,559 Immunomedics Inc shares in Q4 2020, an estimated $11.2M.
  • Natixis first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • Natixis's Immunomedics Inc position peaked at $12.9M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Natixis's 13F filing for Q4 2020, filed 12 Feb 2021.